UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

BACKGROUND: Linaclotide, a guanylate cyclase C agonist, has been shown in clinical trials to improve symptoms of irritable bowel syndrome with constipation (IBS-C). Here we report data from a real-world study of linaclotide in the UK. METHODS: This 1-year, multicentre, prospective, observational stu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Therap Adv Gastroenterol
Prif Awduron: Yiannakou, Yan, Agrawal, Anu, Allen, Patrick B., Arebi, Naila, Brown, Steven R., Eugenicos, Maria P., Farmer, Adam D., McLain-Smith, Su, McLaughlin, John, Sanders, David S., Lawrance, Dominic, Emmanuel, Anton
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2018
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170957/
https://ncbi.nlm.nih.gov/pubmed/30302125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818798791
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg